Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | AGXT | P21549 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16893725 | 1.00 | TDP1 (0.61) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL1534971 | 1.00 | TDP1 (0.61) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL1534924 | 1.00 | TDP1 (0.61) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL16893744 | 1.00 | TDP1 (0.61) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL95651 | 0.98 | TDP1 (0.63) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL7633032 | 0.92 | TDP1 (0.66) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL16902859 | 0.90 | TDP1 (0.73) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL16902857 | 0.90 | TDP1 (0.73) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL16902871 | 0.90 | TDP1 (0.73) | TDP1KDM4EMAPK1HRH3HDAC1 | |
| SCHEMBL16902870 | 0.90 | TDP1 (0.73) | TDP1KDM4EMAPK1HRH3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11952450-B2 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO., LTD. (CN) | 2024-04-09 | — | — | US | claimed |
| US-20220259352-A1 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO., LTD. (CN) | 2022-08-18 | — | — | US | claimed |
| EP-0574355-B1 | Phosphinyloxy propanaminium inner salt derivatives | CIBA GEIGY AG (CH) | 1997-08-13 | — | — | EP | claimed |
| EP-0656008-A1 | THROMBIN RECEPTOR ANTAGONISTS | COR THERAPEUTICS, INC. (US) | 1995-06-07 | — | — | EP | claimed |
| EP-0574355-A1 | Phosphinyloxy propanaminium inner salt derivatives | SANDOZ LTD. (CH) | 1993-12-15 | — | — | EP | claimed |
| US-11952450-B2 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO., LTD. (CN) | 2024-04-09 | — | — | US | disclosed |
| US-20220259352-A1 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO., LTD. (CN) | 2022-08-18 | — | — | US | disclosed |
| CN-112898330-A | Compound for packaging organic light-emitting device and preparation method and application thereof | 吉林奥来德光电材料股份有限公司 | 2021-06-04 | — | — | CN | disclosed |
| US-20150198740-A1 | ORGANIC-INORGANIC HYBRID COMPOSITION, PRODUCTION METHOD FOR SAME, AND OPTICAL SHEET AND OPTICAL DEVICE OF SAME | CHANGKANG CHEMICAL CO., LTD. (KR) | 2015-07-16 | — | — | US | disclosed |
| EP-0656008-A1 | THROMBIN RECEPTOR ANTAGONISTS | COR THERAPEUTICS, INC. (US) | 1995-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259352-A1 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | AOX1, LOXL1, SEM1 | TDP1 2633/4885KDM4E 1440/4885MAPK1 3159/4885 |
| US-11952450-B2 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | TTPA, LOX, AOX1 | TDP1 3350/4885KDM4E 1222/4885MAPK1 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.